CYP27A1 and atherosclerosis: Knockout of Cyp27A1 in apolipoprotein E-deficient mice revealed a gene dose effect with a 10-fold reduction in atherosclerosis severity observed in double knockout mice, and Cyp27A1 heterozygosity leads to accelerated atherosclerosis (226).